Functional influence of botulinum neurotoxin type A treatment (Xeomin®) of multifocal upper and lower limb spasticity on chronic hemiparetic gait

Functional influence of botulinum neurotoxin type A treatment (Xeomin®) of multifocal upper and lower limb spasticity on chronic hemiparetic gait

This report describes the modification of hemiplegic shoulder pain and walking velocity through injections of Xeomin®, a new botulinum neurotoxin type A formulation, in a 67-year-old woman with chronic residual left hemiparesis and hemiparetic gait attributable to stroke. Clinical evaluation include...

Full description

Bibliographic Details
Main Authors: Maurizio Falso, Rosalba Galluso, Andrea Malvicini
Format: Article
Language:English
Published: MDPI AG 2012-05-01
Series:Neurology International
Subjects:
Botulinum neurotoxin type A
Muscle spasticity
Xeomin®
Online Access:http://www.pagepress.org/journals/index.php/ni/article/view/4023

Internet

http://www.pagepress.org/journals/index.php/ni/article/view/4023

Similar Items